The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - BioNTech (I); GANYMED Pharmaceuticals
Leadership - BioNTech (I); GANYMED Pharmaceuticals
Stock and Other Ownership Interests - BioNTech (I)
Consulting or Advisory Role - GANYMED Pharmaceuticals (I)
Patents, Royalties, Other Intellectual Property - BioNTech (I); GANYMED Pharmaceuticals
High Prevalence of Claudin 18.2 Expression in Japanese Patients with Gastric Cancer.
 
Özlem Tureci
No Relationships to Disclose
 
Kyogo Itoh
Stock and Other Ownership Interests - GreenPeptide; GreenPeptide (I)
Research Funding - Taiho Pharmaceutical (Inst)
 
Rin Yamaguchi
Research Funding - Chugai Pharma (Inst)
 
Svetlana Mukhina
Employment - GANYMED Pharmaceuticals; Merck KGaA
 
Ugur Sahin
Employment - BioNTech; GANYMED Pharmaceuticals (I)
Leadership - BioNTech; GANYMED Pharmaceuticals (I)
Stock and Other Ownership Interests - BioNTech
Consulting or Advisory Role - GANYMED Pharmaceuticals
Patents, Royalties, Other Intellectual Property - BioNTech; GANYMED Pharmaceuticals (I)
 
Christoph Rohde
Employment - GANYMED Pharmaceuticals